| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Validity of International Classification of Diseases, Ninth Revision, Clinical Modification Codes for Acute Renal Failure.
|
J Am Soc Nephrol
|
2006
|
4.95
|
|
2
|
Hetastarch and bleeding complications after coronary artery surgery.
|
Chest
|
2003
|
2.87
|
|
3
|
The comparative short-term effectiveness of iron dosing and formulations in US hemodialysis patients.
|
Am J Med
|
2013
|
2.77
|
|
4
|
Comparative mortality risk of anemia management practices in incident hemodialysis patients.
|
JAMA
|
2010
|
2.71
|
|
5
|
Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge: a 10-year trend analysis.
|
J Am Coll Cardiol
|
2008
|
2.58
|
|
6
|
A systematic review of sevelamer in ESRD and an analysis of its potential economic impact in Canada and the United States.
|
Kidney Int
|
2004
|
2.29
|
|
7
|
Infection risk with bolus versus maintenance iron supplementation in hemodialysis patients.
|
J Am Soc Nephrol
|
2013
|
2.06
|
|
8
|
Trends in the use and outcomes of implantable cardioverter-defibrillators in patients undergoing dialysis in the United States.
|
Am J Kidney Dis
|
2011
|
1.92
|
|
9
|
Preoperative statin use and postoperative acute kidney injury.
|
Am J Med
|
2012
|
1.87
|
|
10
|
Educational level as a determinant of access to and outcomes after kidney transplantation in the United States.
|
Am J Kidney Dis
|
2008
|
1.84
|
|
11
|
Nephrologist care and mortality in patients with chronic renal insufficiency.
|
Arch Intern Med
|
2002
|
1.82
|
|
12
|
Epidemiology and sociodemographics of systemic lupus erythematosus and lupus nephritis among US adults with Medicaid coverage, 2000-2004.
|
Arthritis Rheum
|
2013
|
1.80
|
|
13
|
Commentary on 'The DOPPS practice monitor for U.S. dialysis care: update on trends in anemia management 2 years into the bundle': iron(y) abounds 2 years later.
|
Am J Kidney Dis
|
2013
|
1.76
|
|
14
|
Delayed nephrologist referral and inadequate vascular access in patients with advanced chronic kidney failure.
|
J Clin Epidemiol
|
2002
|
1.73
|
|
15
|
Variation in nephrologist visits to patients on hemodialysis across dialysis facilities and geographic locations.
|
Clin J Am Soc Nephrol
|
2013
|
1.69
|
|
16
|
Trends in the incidence, demographics, and outcomes of end-stage renal disease due to lupus nephritis in the US from 1995 to 2006.
|
Arthritis Rheum
|
2011
|
1.68
|
|
17
|
The hepatotoxicity of antifungal medications in bone marrow transplant recipients.
|
Clin Infect Dis
|
2005
|
1.67
|
|
18
|
Trends in anemia care in older patients approaching end-stage renal disease in the United States (1995-2010).
|
JAMA Intern Med
|
2014
|
1.58
|
|
19
|
Variation in initial kidney replacement therapy for end-stage renal disease due to lupus nephritis in the United States.
|
Arthritis Care Res (Hoboken)
|
2011
|
1.57
|
|
20
|
Predicting survival in patients requiring renal replacement therapy after cardiac surgery.
|
Ann Thorac Surg
|
2006
|
1.53
|
|
21
|
Long-term patient and graft survival in the eurotransplant senior program: a single-center experience.
|
Transplantation
|
2005
|
1.51
|
|
22
|
Trends in adherence to secondary prevention medications in elderly post-myocardial infarction patients.
|
Pharmacoepidemiol Drug Saf
|
2008
|
1.45
|
|
23
|
Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation.
|
J Am Soc Nephrol
|
2006
|
1.43
|
|
24
|
Multivessel coronary artery bypass grafting versus percutaneous coronary intervention in ESRD.
|
J Am Soc Nephrol
|
2012
|
1.42
|
|
25
|
Use of Medicare data to identify coronary heart disease outcomes in the Women's Health Initiative.
|
Circ Cardiovasc Qual Outcomes
|
2014
|
1.41
|
|
26
|
Validation of reported predialysis nephrology care of older patients initiating dialysis.
|
J Am Soc Nephrol
|
2012
|
1.36
|
|
27
|
Knowledge and attitude regarding organ donation among medical students and physicians.
|
Transplantation
|
2004
|
1.31
|
|
28
|
Surrogate markers in clinical studies: problems solved or created?
|
Am J Kidney Dis
|
2006
|
1.28
|
|
29
|
Trends in acute nonvariceal upper gastrointestinal bleeding in dialysis patients.
|
J Am Soc Nephrol
|
2012
|
1.27
|
|
30
|
How well do patients report noncompliance with antihypertensive medications?: a comparison of self-report versus filled prescriptions.
|
Pharmacoepidemiol Drug Saf
|
2004
|
1.24
|
|
31
|
Impact of Medicaid prior authorization on angiotensin-receptor blockers: can policy promote rational prescribing?
|
Health Aff (Millwood)
|
2007
|
1.22
|
|
32
|
Ten-year trends of cardiovascular drug use after myocardial infarction among community-dwelling persons > or =65 years of age.
|
Am J Cardiol
|
2007
|
1.21
|
|
33
|
End-stage renal disease due to lupus nephritis among children in the US, 1995-2006.
|
Arthritis Rheum
|
2011
|
1.17
|
|
34
|
The prevalence and cost of unapproved uses of top-selling orphan drugs.
|
PLoS One
|
2012
|
1.14
|
|
35
|
Prevalence, incidence, and demographics of systemic lupus erythematosus and lupus nephritis from 2000 to 2004 among children in the US Medicaid beneficiary population.
|
Arthritis Rheum
|
2012
|
1.11
|
|
36
|
Trends in acute kidney injury, associated use of dialysis, and mortality after cardiac surgery, 1999 to 2008.
|
Ann Thorac Surg
|
2012
|
1.10
|
|
37
|
Saving the kidneys by sparing intravenous chloride?
|
JAMA
|
2012
|
1.07
|
|
38
|
Evolving statistical methods to facilitate evaluation of the causal association between erythropoiesis-stimulating agent dose and mortality in nonexperimental research: strengths and limitations.
|
Am J Kidney Dis
|
2009
|
1.07
|
|
39
|
Comparison of Medicare claims versus physician adjudication for identifying stroke outcomes in the Women's Health Initiative.
|
Stroke
|
2014
|
1.05
|
|
40
|
The 2011 ESRD prospective payment system: an uncontrolled experiment.
|
Am J Kidney Dis
|
2011
|
1.05
|
|
41
|
Differences in access to kidney transplantation between Hispanic and non-Hispanic whites by geographic location in the United States.
|
Clin J Am Soc Nephrol
|
2013
|
1.05
|
|
42
|
The cost-effectiveness of maintaining higher hemoglobin targets with erythropoietin in hemodialysis patients.
|
Kidney Int
|
2003
|
1.05
|
|
43
|
Patient and graft survival in older kidney transplant recipients: does age matter?
|
J Am Soc Nephrol
|
2004
|
1.02
|
|
44
|
Medication adherence after myocardial infarction: a long way left to go.
|
J Gen Intern Med
|
2008
|
1.01
|
|
45
|
Temporal trends in the incidence, treatment, and outcomes of hip fracture in older patients initiating dialysis in the United States.
|
Clin J Am Soc Nephrol
|
2013
|
1.01
|
|
46
|
The effect of altitude on dosing and response to erythropoietin in ESRD.
|
J Am Soc Nephrol
|
2008
|
1.00
|
|
47
|
Fostering innovation, advancing patient safety: the kidney health initiative.
|
Clin J Am Soc Nephrol
|
2013
|
1.00
|
|
48
|
Trends in the incidence of atrial fibrillation in older patients initiating dialysis in the United States.
|
Circulation
|
2012
|
0.99
|
|
49
|
Determinants of peritoneal dialysis technique failure in incident US patients.
|
Perit Dial Int
|
2012
|
0.99
|
|
50
|
Trends in relative mortality between Hispanic and non-Hispanic whites initiating dialysis: a retrospective study of the US Renal Data System.
|
Am J Kidney Dis
|
2013
|
0.99
|
|
51
|
Chronic on acute renal failure: long-term implications of severe acute kidney injury.
|
JAMA
|
2009
|
0.98
|
|
52
|
Greater Epoetin alfa (EPO) doses and short-term mortality risk among hemodialysis patients with hemoglobin levels less than 11 g/dL.
|
Pharmacoepidemiol Drug Saf
|
2009
|
0.97
|
|
53
|
Use and safety of unfractionated heparin for anticoagulation during maintenance hemodialysis.
|
Am J Kidney Dis
|
2012
|
0.97
|
|
54
|
Hispanic ethnicity and vascular access use in patients initiating hemodialysis in the United States.
|
Clin J Am Soc Nephrol
|
2011
|
0.96
|
|
55
|
Intravenous iron supplementation practices and short-term risk of cardiovascular events in hemodialysis patients.
|
PLoS One
|
2013
|
0.96
|
|
56
|
Anticoagulation for atrial fibrillation in patients on dialysis: are the benefits worth the risks?
|
Curr Opin Nephrol Hypertens
|
2012
|
0.96
|
|
57
|
Kidney function and long-term medication adherence after myocardial infarction in the elderly.
|
Clin J Am Soc Nephrol
|
2011
|
0.95
|
|
58
|
Use and safety of heparin-free maintenance hemodialysis in the USA.
|
Nephrol Dial Transplant
|
2013
|
0.94
|
|
59
|
Gender differences in the management and prognosis of myocardial infarction among patients > or = 65 years of age.
|
Am J Cardiol
|
2008
|
0.94
|
|
60
|
Prognostic associations of serum calcium, phosphate and calcium phosphate concentration product with outcomes in kidney transplant recipients.
|
Transpl Int
|
2007
|
0.93
|
|
61
|
Comparative effectiveness research: what is it and why do we need it in nephrology?
|
Nephrol Dial Transplant
|
2012
|
0.92
|
|
62
|
Statins in elderly patients with acute coronary syndrome: an analysis of dose and class effects in typical practice.
|
Heart
|
2007
|
0.92
|
|
63
|
Cardiovascular risk and the thiazolidinediones: déjà vu all over again?
|
JAMA
|
2007
|
0.91
|
|
64
|
Comparison of two dosages of thymoglobulin used as a short-course for induction in kidney transplantation.
|
Transpl Int
|
2006
|
0.91
|
|
65
|
Long-term trends of angiotensin-converting enzyme inhibitor and angiotensin-receptor blocker use after heart failure hospitalization in community-dwelling seniors.
|
Int J Cardiol
|
2007
|
0.91
|
|
66
|
Treated and untreated kidney failure in older adults: what's the right balance?
|
JAMA
|
2012
|
0.90
|
|
67
|
Phosphate binder choice in dialysis patients: a call for evidence-based rather than marketing-based clinical practice.
|
Am J Kidney Dis
|
2008
|
0.89
|
|
68
|
Medication issues in older individuals with CKD.
|
Adv Chronic Kidney Dis
|
2010
|
0.88
|
|
69
|
Cost-effectiveness of fixed-dose combination of isosorbide dinitrate and hydralazine therapy for blacks with heart failure.
|
Circulation
|
2005
|
0.88
|
|
70
|
World Kidney Day 2011.
|
J Am Soc Nephrol
|
2011
|
0.87
|
|
71
|
Associations between demographic factors and provider structures on cost and length of stay for hemodialysis patients with vascular access failure.
|
Clin J Am Soc Nephrol
|
2006
|
0.87
|
|
72
|
Early erythropoietin therapy is associated with improved growth in children with chronic kidney disease.
|
Pediatr Nephrol
|
2007
|
0.87
|
|
73
|
ACE inhibitor and angiotensin II type 1 receptor antagonist therapies in elderly patients with diabetes mellitus: are they underutilized?
|
Drugs Aging
|
2010
|
0.87
|
|
74
|
Near-term prediction of sudden cardiac death in older hemodialysis patients using electronic health records.
|
Clin J Am Soc Nephrol
|
2013
|
0.86
|
|
75
|
Methionine synthase reductase MTRR 66A > G has no effect on total homocysteine, folate, and Vitamin B12 concentrations in renal transplant patients.
|
Atherosclerosis
|
2004
|
0.86
|
|
76
|
Risk factors of short-term mortality after acute nonvariceal upper gastrointestinal bleeding in patients on dialysis: a population-based study.
|
BMC Nephrol
|
2013
|
0.86
|
|
77
|
Renal dysfunction increases the risk of saphenous vein graft occlusion: results from the Post-CABG trial.
|
Atherosclerosis
|
2006
|
0.86
|
|
78
|
Factors affecting response and tolerability to ferumoxytol in nondialysis chronic kidney disease patients.
|
Clin Nephrol
|
2012
|
0.84
|
|
79
|
Epidemiologic and statistical methods for comparative effectiveness research.
|
Heart Fail Clin
|
2012
|
0.84
|
|
80
|
Lessons from geographic variations in predialysis nephrology care.
|
J Am Soc Nephrol
|
2009
|
0.84
|
|
81
|
Prognostic associations between lipid markers and outcomes in kidney transplant recipients.
|
Am J Kidney Dis
|
2006
|
0.84
|
|
82
|
The association between angiotensin converting enzyme inhibitor or angiotensin receptor blocker use during postischemic acute transplant failure and renal allograft survival.
|
Transplantation
|
2006
|
0.83
|
|
83
|
What caused excess strokes in patients randomized to darbepoetin in the trial to reduce cardiovascular events with Aranesp therapy (TREAT)?: no smoking gun.
|
Circulation
|
2011
|
0.83
|
|
84
|
Propensity scores in the presence of effect modification: A case study using the comparison of mortality on hemodialysis versus peritoneal dialysis.
|
Emerg Themes Epidemiol
|
2010
|
0.83
|
|
85
|
Posttransplantation anemia: mechanisms and management.
|
Clin J Am Soc Nephrol
|
2011
|
0.83
|
|
86
|
Incidence, correlates, and consequences of acute kidney injury in patients with pulmonary arterial hypertension hospitalized with acute right-side heart failure.
|
J Card Fail
|
2011
|
0.83
|
|
87
|
Comparing the costs, risks, and benefits of competing strategies for the primary prevention of venous thromboembolism.
|
Circulation
|
2004
|
0.83
|
|
88
|
On the relative safety of intravenous iron formulations: new answers, new questions.
|
Am J Hematol
|
2010
|
0.82
|
|
89
|
Effect of conversion from ciclosporin to tacrolimus on endothelial progenitor cells in stable long-term kidney transplant recipients.
|
Transplantation
|
2013
|
0.81
|
|
90
|
Endothelial progenitor cells in kidney transplant recipients.
|
Transplantation
|
2006
|
0.81
|
|
91
|
Angiotensin-converting enzyme inhibitors and cardiovascular outcomes in patients on maintenance hemodialysis.
|
Am Heart J
|
2011
|
0.80
|
|
92
|
Genetic aspects of hyperhomocysteinemia in chronic kidney disease.
|
Semin Nephrol
|
2006
|
0.79
|
|
93
|
Trends in the incidence of intestinal perforation in US dialysis patients (1992-2005).
|
J Nephrol
|
2012
|
0.79
|
|
94
|
The effect of altitude change on anemia treatment response in hemodialysis patients.
|
Am J Epidemiol
|
2011
|
0.79
|
|
95
|
Analysis of the cardiovascular risk profile in stable kidney transplant recipients after 50% cyclosporine reduction.
|
Clin Transplant
|
2004
|
0.78
|
|
96
|
Strategies for the management of suspected heparin-induced thrombocytopenia: a cost-effectiveness analysis.
|
Pharmacoeconomics
|
2007
|
0.78
|
|
97
|
Nononcologic use of human recombinant erythropoietin therapy in hospitalized patients.
|
Arch Intern Med
|
2007
|
0.78
|
|
98
|
Quantifying the benefit of early living-donor renal transplantation with a simulation model of the Dutch renal replacement therapy population.
|
Nephrol Dial Transplant
|
2011
|
0.78
|
|
99
|
Against TREATing all patients alike: lessons from an FDA Advisory Committee Meeting.
|
J Am Soc Nephrol
|
2010
|
0.78
|
|
100
|
More evidence on an abominable pairing: atrial fibrillation and kidney disease.
|
Circulation
|
2013
|
0.77
|
|
101
|
Kidney disease and antihypertensive medication adherence: the need for improved measurement tools.
|
Am J Kidney Dis
|
2010
|
0.77
|
|
102
|
HMG-CoA reductase inhibitors in kidney transplant recipients receiving tacrolimus: statins not associated with improved patient or graft survival.
|
BMC Nephrol
|
2010
|
0.77
|
|
103
|
Use of secondary prevention medications among adults with reduced kidney function.
|
Clin J Am Soc Nephrol
|
2012
|
0.77
|
|
104
|
Effect of hemodialysis before transplant surgery on renal allograft function--a pair of randomized controlled trials.
|
Transplantation
|
2009
|
0.76
|
|
105
|
Air pollution and coronary risk in kidney transplant recipients.
|
Am J Kidney Dis
|
2011
|
0.76
|
|
106
|
Approaching the end of the homocysteine hype?
|
Am J Kidney Dis
|
2008
|
0.75
|
|
107
|
Multivessel coronary revascularization and outcomes in kidney transplant recipients.
|
Transpl Int
|
2013
|
0.75
|
|
108
|
Kidney disease and cardiovascular risk: whether black or white race matters.
|
JAMA
|
2013
|
0.75
|
|
109
|
Tackling the Achilles' heel of hemodialysis.
|
N Engl J Med
|
2011
|
0.75
|
|
110
|
Commentary on 'The DOPPS practice monitor for US dialysis care: trends through August 2011': an ESA confluence.
|
Am J Kidney Dis
|
2012
|
0.75
|
|
111
|
Commentary on 'The DOPPS Practice Monitor for US dialysis care: trends through December 2011': results from year one.
|
Am J Kidney Dis
|
2013
|
0.75
|
|
112
|
The challenges of cost-effectiveness analyses for the clinician.
|
Am J Kidney Dis
|
2010
|
0.75
|
|
113
|
Predicting the outcomes of rhabdomyolysis: a good starting point.
|
JAMA Intern Med
|
2013
|
0.75
|
|
114
|
Assessments of causal effects--theoretically sound, practically unattainable, and clinically not so relevant.
|
Clin J Am Soc Nephrol
|
2013
|
0.75
|
|
115
|
Strategies for postmarketing surveillance of drugs and devices in patients with ESRD undergoing dialysis.
|
Clin J Am Soc Nephrol
|
2013
|
0.75
|
|
116
|
Effects of physician payment reform on provision of home dialysis.
|
Am J Manag Care
|
2016
|
0.75
|
|
117
|
Review: In CKD, novel oral anticoagulants do not differ from vitamin K antagonists for efficacy or bleeding.
|
Ann Intern Med
|
2014
|
0.75
|
|
118
|
Heparin use in hemodialysis patients following gastrointestinal bleeding.
|
Am J Nephrol
|
2014
|
0.75
|
|
119
|
Menopausal symptoms in women with chronic kidney disease.
|
Menopause
|
2015
|
0.75
|
|
120
|
Off-label use of phosphate binders in non-dialysis-dependent CKD.
|
Am J Kidney Dis
|
2010
|
0.75
|
|
121
|
Regarding impact of epoetin alfa on clinical end points in patients with chronic renal failure: a meta-analysis.
|
Kidney Int
|
2004
|
0.75
|
|
122
|
A randomized, double-blind, placebo-controlled trial of calcium acetate on serum phosphorus concentrations in patients with advanced non-dialysis-dependent chronic kidney disease.
|
BMC Nephrol
|
2011
|
0.75
|
|
123
|
Causal or casual?-The association between consumption of artificially sweetened carbonated beverages and vascular disease.
|
J Gen Intern Med
|
2012
|
0.75
|
|
124
|
Correlates and variance decomposition analysis of heparin dosing for maintenance hemodialysis in older US patients.
|
Pharmacoepidemiol Drug Saf
|
2014
|
0.75
|
|
125
|
IV iron dosing regimens: choice of agent and dosing frequency.
|
Nephrol News Issues
|
2014
|
0.75
|
|
126
|
Potential savings in prescription drug costs for hypertension, hyperlipidemia, and diabetes mellitus by equivalent drug substitution in Austria: a nationwide cohort study.
|
Appl Health Econ Health Policy
|
2015
|
0.75
|
|
127
|
The Effect of ABCB1 Polymorphisms on Serial Tacrolimus Concentrations in Stable Austrian Long-Term Kidney Transplant Recipients.
|
Clin Lab
|
2017
|
0.75
|
|
128
|
Validating identification of patients with small vessel vasculitis, with or without renal involvement, using administrative healthcare records.
|
Clin Nephrol
|
2017
|
0.75
|
|
129
|
Drug-Eluting Stents Versus Bare Metal Stents for Percutaneous Coronary Intervention in Kidney Transplant Recipients.
|
Transplantation
|
2017
|
0.75
|
|
130
|
No associations between prolactin concentrations and response to erythropoiesis-stimulating agents in hemodialysis patients.
|
Am J Nephrol
|
2007
|
0.75
|
|
131
|
Kidney Transplantation Rates Across Glomerulonephritis Subtypes in the United States.
|
Transplantation
|
2017
|
0.75
|